PT100668B - Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos - Google Patents

Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos Download PDF

Info

Publication number
PT100668B
PT100668B PT100668A PT10066892A PT100668B PT 100668 B PT100668 B PT 100668B PT 100668 A PT100668 A PT 100668A PT 10066892 A PT10066892 A PT 10066892A PT 100668 B PT100668 B PT 100668B
Authority
PT
Portugal
Prior art keywords
corydalis
extract
extracts
pharmaceutical composition
eschsoltzia
Prior art date
Application number
PT100668A
Other languages
English (en)
Portuguese (pt)
Other versions
PT100668A (pt
Inventor
Werner Schneider
Erich F Elstner
Elisabeth Kleber
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of PT100668A publication Critical patent/PT100668A/pt
Publication of PT100668B publication Critical patent/PT100668B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT100668A 1991-07-09 1992-07-08 Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos PT100668B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (enExample) 1991-07-09 1991-07-09

Publications (2)

Publication Number Publication Date
PT100668A PT100668A (pt) 1993-09-30
PT100668B true PT100668B (pt) 1999-08-31

Family

ID=6435763

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100668A PT100668B (pt) 1991-07-09 1992-07-08 Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos

Country Status (26)

Country Link
US (1) US5308619A (enExample)
EP (1) EP0535317B1 (enExample)
JP (1) JPH085796B2 (enExample)
KR (1) KR100225010B1 (enExample)
AT (1) ATE139446T1 (enExample)
AU (1) AU652262B2 (enExample)
CA (1) CA2072950A1 (enExample)
CZ (1) CZ279915B6 (enExample)
DE (2) DE4122706C1 (enExample)
DK (1) DK0535317T3 (enExample)
EE (1) EE03169B1 (enExample)
EG (1) EG20140A (enExample)
ES (1) ES2088053T3 (enExample)
GR (1) GR3020289T3 (enExample)
HU (1) HUT61668A (enExample)
IE (1) IE74691B1 (enExample)
IL (1) IL102410A (enExample)
MD (1) MD1139G2 (enExample)
MX (1) MX9204011A (enExample)
PT (1) PT100668B (enExample)
RU (1) RU2072859C1 (enExample)
SI (1) SI9200138A (enExample)
SK (1) SK279531B6 (enExample)
UA (1) UA26971C2 (enExample)
YU (1) YU48554B (enExample)
ZA (1) ZA925059B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
PT1066042E (pt) * 1998-03-26 2006-12-29 Phytopharm Plc Saponinas esteroides para o tratamento de doença de alzheimer
NZ514253A (en) 1999-03-11 2003-06-30 Zeachem Inc Process for producing ethanol
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
NZ586246A (en) * 2004-01-29 2013-03-28 Zeachem Inc Recovery of organic acids from a fermentation broth
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (enExample) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Also Published As

Publication number Publication date
EG20140A (en) 1997-07-31
GR3020289T3 (en) 1996-09-30
EE03169B1 (et) 1999-04-15
IE922226A1 (en) 1993-01-13
MD1139G2 (ro) 1999-10-31
ES2088053T3 (es) 1996-08-01
KR100225010B1 (ko) 1999-10-15
DE4122706C1 (enExample) 1993-03-04
JPH085796B2 (ja) 1996-01-24
ATE139446T1 (de) 1996-07-15
RU2072859C1 (ru) 1997-02-10
IL102410A (en) 1998-02-22
JPH0753392A (ja) 1995-02-28
AU1937092A (en) 1993-01-14
UA26971C2 (uk) 2000-02-28
CZ214392A3 (en) 1993-02-17
CA2072950A1 (en) 1993-01-10
SK214392A3 (en) 1994-11-09
ZA925059B (en) 1993-04-28
HUT61668A (en) 1993-03-01
IE74691B1 (en) 1997-07-30
MD1139F2 (en) 1999-01-31
YU48554B (sh) 1998-11-05
KR930001926A (ko) 1993-02-22
SI9200138A (en) 1993-03-31
YU67492A (sr) 1996-01-09
US5308619A (en) 1994-05-03
MD950171A (en) 1996-06-28
AU652262B2 (en) 1994-08-18
EP0535317B1 (de) 1996-06-19
SK279531B6 (sk) 1998-12-02
PT100668A (pt) 1993-09-30
HU9202274D0 (en) 1992-10-28
DK0535317T3 (da) 1996-07-15
EP0535317A1 (de) 1993-04-07
CZ279915B6 (cs) 1995-08-16
MX9204011A (es) 1993-07-01
IL102410A0 (en) 1993-01-14
DE59206608D1 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
Prange et al. L-tryptophan in mania: Contribution to a permissive hypothesis of affective disorders
EP1377278B1 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
HUP0002628A2 (en) Pharmaceutical combinations for treating diabetes
PT100668B (pt) Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos
CN107441104B (zh) 人参二醇皂苷Rb组分防治糖尿病并发症及代谢紊乱相关疾病的医药用途
RU2125448C1 (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
Sung et al. Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men
Medon et al. Influence of quipazine, a potential anti-parkinsonian agent on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitro
US20020058712A1 (en) Treatment of fibromyalgia with ubiquinone 10 and succinic acid
FI117374B (fi) Hyperglykemian vastaisesti vaikuttavat lääkeaineet
Hashim Fauzy et al. Piper sarmentosum leaves aqueous extract attenuates vascular endothelial dysfunction in spontaneously hypertensive rats
Wirz-Justice et al. Increased platelet serotonin in bipolar depression and hypomania
Duraisami et al. Evaluation of antidiabetic efficacy of polyherbal formulations in experimentally induced hyperglycemic rats
Surapongchai et al. Angiotensin II induces differential insulin action in rat skeletal muscle
KR0168748B1 (ko) 혈당 강하용 인삼 음료와 소프트 캡슐
RU2146529C1 (ru) Набор антиалкогольных средств
Hedner et al. Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man
WO2000045809A1 (en) L-arginine based formulations for treating diseases and methods of using same
LT3355B (en) Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
JP2008074796A (ja) 抗糖尿病食品
US5180739A (en) Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases
CN109820889A (zh) 丹参提取物在制备蛋白酪氨酸磷酸酶1b抑制剂及预防和/或治疗2型糖尿病药物中的应用
US20050215644A1 (en) Methods for increasing neurotransmitter levels using hydroxycitric acid
KR100773246B1 (ko) 연령초 추출물을 유효성분으로 함유하는 비만 억제 및 혈당강하용 조성물
Yoshikawa Xylitol infusion related to pathophysiology in anesthesia

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930507

FG3A Patent granted, date of granting

Effective date: 19990511

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20011130